EP Patent

EP4302831A1 — Process for synthesis of tirbanibulin

Assigned to TRIFARMA SpA · Expires 2024-01-10 · 2y expired

What this patent protects

Disclosed is a procedure for the synthesis of tirbanibulin (N-benzyl-2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl) acetamide) of formula I, wherein the key step involves constructing the 3-pyridylphenyl system by means of a Suzuki reaction between an ester of 2-(5-bromopyrid…

USPTO Abstract

Disclosed is a procedure for the synthesis of tirbanibulin (N-benzyl-2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl) acetamide) of formula I, wherein the key step involves constructing the 3-pyridylphenyl system by means of a Suzuki reaction between an ester of 2-(5-bromopyridin-2-yl )acetic acid and 4-hydroxyphenylboronic acid.

Drugs covered by this patent

Patent Metadata

Patent number
EP4302831A1
Jurisdiction
EP
Classification
—
Expires
2024-01-10
Drug substance claim
No
Drug product claim
No
Assignee
TRIFARMA SpA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.